193 related articles for article (PubMed ID: 34504642)
21. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Zhu Y; Zhu C; Yang H; Deng J; Fan D
Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
[TBL] [Abstract][Full Text] [Related]
22. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
Zhang X; Guan T; Yang B; Gu HF; Chi Z
Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
[TBL] [Abstract][Full Text] [Related]
23. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
25. A proteoglycan isolated from Ganoderma lucidum attenuates diabetic kidney disease by inhibiting oxidative stress-induced renal fibrosis both in vitro and in vivo.
Pan Y; Zhang Y; Li J; Zhang Z; He Y; Zhao Q; Yang H; Zhou P
J Ethnopharmacol; 2023 Jun; 310():116405. PubMed ID: 36966849
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
27. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
28. Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats.
Zhou F; Zou X; Zhang J; Wang Z; Yang Y; Wang D
Front Pharmacol; 2021; 12():630210. PubMed ID: 33841151
[TBL] [Abstract][Full Text] [Related]
29. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.
Zhang X; He H; Liang D; Jiang Y; Liang W; Chi ZH; Ma J
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529235
[TBL] [Abstract][Full Text] [Related]
30. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
31. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.
Liu Y; Wang S; Jin G; Gao K; Wang S; Zhang X; Zhou K; Cai Y; Zhou X; Zhao Z
Phytomedicine; 2023 Sep; 118():154915. PubMed ID: 37392674
[TBL] [Abstract][Full Text] [Related]
32. Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress.
Han J; Pang X; Shi X; Zhang Y; Peng Z; Xing Y
Biomed Res Int; 2021; 2021():6657206. PubMed ID: 33860049
[TBL] [Abstract][Full Text] [Related]
33. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X
Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy.
Chang YT; Chung MC; Hsieh CC; Shieh JJ; Wu MJ
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437430
[TBL] [Abstract][Full Text] [Related]
36. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
37. Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis.
Kong X; Zhao Y; Wang X; Yu Y; Meng Y; Yan G; Yu M; Jiang L; Song W; Wang B; Wang X
Chem Biol Interact; 2023 Sep; 382():110640. PubMed ID: 37473909
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
Zhang C; Li Q; Lai S; Yang L; Shi G; Wang Q; Luo Z; Zhao R; Yu Y
J Ethnopharmacol; 2017 Jun; 205():207-216. PubMed ID: 28501426
[TBL] [Abstract][Full Text] [Related]
39. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
[TBL] [Abstract][Full Text] [Related]
40. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
